ACW - Very bullish update released & chart broke out yesterday
(Below from Outlook statement on page 2 of ann)
“The XanaHES results are the first time Xanamem has shown such a clear and statistically significant cognitive improvement in human trials. These results are hugely significant in the development of Xanamem for the treatment of Alzheimer’s disease, and other conditions associated with cognitive impairment,” said Dr Ketelbey.
Over in the USA, Biogen (BIIB) put on Aud 17B in mkt cap 2 nights ago for beginning to re-test a failed Alzheimer's drug... It put on 425x ACW's current mkt cap...
Alzheimer's is ridiculously huge & ACW have made a "hugely significant development"
